Clinical Trial Update: Adolescent Type 1 Diabetes Treatment With SGLT2i for hyperglycEMia & hyPerfilTration Trial [Phase 3]

View source ↗

Summary

A Phase 3 trial update for adolescents with Type 1 diabetes evaluating an SGLT2 inhibitor for hyperglycemia and hyperelevation (hyperglycemia & hyperfiltration)…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• SGLT2 inhibitor

Snippet

Sponsor: The Hospital for Sick Children | Conditions: Diabetes Mellitus, Type 1 | Phase 3 | Status: UNKNOWN